The Centre for Applied Dementia Studies, Faculty of Health Studies, University of Bradford, Bradford BD7 1DP, UK.
DSDC Wales Research Centre, School of Health Sciences, Bangor University, Bangor LL57 2PZ, UK.
Int J Environ Res Public Health. 2024 Feb 16;21(2):231. doi: 10.3390/ijerph21020231.
The pathways for receiving a diagnosis of a rare type of dementia are poorly understood. Diagnostic challenges decrease access to relevant health promotion activities and post-diagnostic support. This study was focused on pathways experienced by people affected by rare dementia in Wales, United Kingdom (UK), considering the practical, emotional, and economic consequences. Semi-structured interviews were completed with 10 people affected by rare dementia across Wales, UK (nine family caregivers and one person living with rare dementia). The interview data were subject to a thematic analysis and a bottom-up costing approach was used to cost the pathway journeys. Five transitional points occurred across the diagnostic pathway (initial contact, initial referral, further referrals-provider, further referrals-private, and diagnosis) alongside two further themes (i.e., involved in the diagnostic process and disputes between stakeholders). The timeliness of the diagnosis was perceived to often be subject to 'luck', with access to private healthcare a personal finance option to expedite the process. Higher economic costs were observed when, in retrospect, inappropriate referrals were made, or multiple referrals were required. The confusion and disputes relating to individual diagnostic pathways led to further emotional burdens, suggesting that higher economic costs and emotional consequences are interlinked. Clearer diagnostic pathways for rare dementia may prevent unnecessary service contacts, waiting times, and associated distress. Prioritising appropriate and timely service contacts leads to diagnosis and support to families and enables people to increase control over their health. Appropriate diagnostic pathways may be less costly and reduce costs for families.
人们对诊断罕见类型痴呆的途径了解甚少。诊断方面的挑战导致他们难以获得相关的健康促进活动和诊断后的支持。本研究关注的是英国威尔士地区受罕见痴呆影响的人群所经历的途径,同时考虑到实际、情感和经济方面的后果。研究人员对英国威尔士地区的 10 名受罕见痴呆影响的人(9 名家属照顾者和 1 名患有罕见痴呆的患者)进行了半结构化访谈。访谈数据进行了主题分析,并采用自下而上的成本核算方法来核算途径的成本。在诊断途径中,有五个过渡点(最初的接触、最初的转诊、进一步的转诊-提供者、进一步的转诊-私人,以及诊断),以及两个进一步的主题(即参与诊断过程和利益相关者之间的争议)。诊断的及时性通常被认为是“运气”的问题,获得私人医疗保健是一种个人财务选择,可以加速这一过程。当回顾时,如果做出了不恰当的转诊,或者需要多次转诊,就会观察到更高的经济成本。与个体诊断途径相关的困惑和争议导致了更大的情感负担,这表明更高的经济成本和情感后果是相互关联的。罕见痴呆症更清晰的诊断途径可以防止不必要的服务接触、等待时间和相关的困扰。优先考虑适当和及时的服务接触可以促进诊断,并为家庭提供支持,使人们能够增加对自己健康的控制。适当的诊断途径可能成本更低,并为家庭减少成本。